Management of Car Sickness in Pediatric Patients
For pediatric car sickness, first-line treatment includes non-pharmacological strategies, with antihistamines like dimenhydrinate or diphenhydramine as the pharmacological option of choice when necessary.
Understanding Car Sickness in Children
Car sickness is a form of motion sickness that commonly affects children between 2-12 years of age, with girls being more susceptible than boys 1. It occurs due to sensory conflict between visual, vestibular, and proprioceptive systems when traveling in vehicles.
Common Symptoms
- Early signs: stomach awareness, malaise, drowsiness, irritability
- Progressive symptoms: nausea, vomiting, pallor, sweating
- Associated symptoms: headache, fatigue, disorientation
Non-Pharmacological Management (First-Line)
Positioning Strategies
- Place child in the middle of the back seat where motion is minimized 2
- Never place young children in the front seat - rear seating reduces risk of death by 50% and serious injury by 60% for children under 4 years 3
- Have the child face forward and look at the horizon through the windshield
- Ensure the child is properly secured in an age-appropriate car seat
Behavioral Approaches
- Encourage the child to focus on distant objects or the true horizon
- Avoid reading books or using electronic devices during travel
- Have the child lie down with eyes closed if symptoms develop
- Provide adequate ventilation in the vehicle
- Plan for frequent stops during longer journeys
- Gradually increase exposure to car travel to promote habituation 4
Other Considerations
- Avoid heavy meals before travel
- Provide small, bland snacks rather than traveling on an empty stomach
- Ensure adequate hydration
- Schedule travel during times when the child is likely to sleep
- Distract with music, conversation, or audio stories (rather than visual entertainment)
Pharmacological Management (When Non-Pharmacological Methods Fail)
First-Line Medications
- Antihistamines (H1-blockers):
Second-Line Medications (for older children)
- Scopolamine: Available as transdermal patches for children >12 years
Special Considerations
Age-Specific Concerns
- Children under 2 years: Rarely affected by motion sickness
- Children 2-12 years: Most susceptible age group 1
- Adolescents: Susceptibility begins to decrease
Medication Cautions
- Avoid promethazine (Phenergan) in children under 2 years due to "black box warning" for fatal respiratory depression 5
- Be aware that sedating medications may cause paradoxical excitation in some children
- Always use weight-based dosing for pediatric patients
Safety Considerations
- Children who are sedated from motion sickness medications require close monitoring
- Ensure proper car seat positioning and restraint use at all times
- For infants and toddlers in car safety seats, be vigilant about potential airway obstruction if sedated 5
Prevention for Future Travel
- Begin with non-pharmacological strategies for all children
- If medication is necessary, administer before symptoms develop
- Consider gradual exposure therapy to build tolerance
- For children with severe or recurrent symptoms, consult with a pediatrician before long journeys
By implementing these strategies, most cases of pediatric car sickness can be effectively managed, improving the travel experience for both children and their families.